Skip to content

Evaluation of Mental and Psychological Disorders in Functional Gastrointestinal Disease Patients by VibraImage Technology

Evaluation of Mental and Psychological Disorders in Functional Gastrointestinal Disease Patients by VibraImage Technology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080796
Enrollment
Unknown
Registered
2024-02-07
Start date
2024-02-19
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional gastrointestinal disease

Interventions

Functional gastrointestinal disease with psychological disorders/ Functional gastrointestinal disease without psychological disorders:None

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. A patient who was diagnosed with FGID at the gastroenterology department of Peking Union Medical College hospital and agreed to continue with our follow-up. 2. Agree to the VibraImage collection and conduct FGIDs scales and HADS psychological self-assessment. 3. FGID diagnosis meets the Roman IV diagnostic criteria, including (1) functional dyspepsia. (2) Irritable bowel syndrome. (3) Chronic constipation/diarrhea. (4) Central mediated abdominal pain syndrome. (5) Functional esophageal disease. (6) Functional anorectal diseases. 4. Age between18-80 years old. 5. Able to sign and provide informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Serious comorbidities that affect medication (such as severe liver dysfunction, renal failure, and congestive heart failure). 2. Existence of celiac disease, IBD, or other organic gastrointestinal diseases. 3. Pregnancy or lactation period. 4. Diseases that affect gastrointestinal motility. 5. The drugs currently used include antipsychotic drugs, antispasmodic drugs, antidiarrheals, probiotics, antibiotics, and any other drugs used to treat abdominal pain, intestinal peristalsis disorders, and disturbances in gastrointestinal motility.

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale;VibraImage data;

Secondary

MeasureTime frame
Scales of FGIDs severity;

Countries

China

Contacts

Public ContactYang Chen

Peking Union Medical College Hospital

dr_chenyang@126.com+86 185 1155 8069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026